Patents by Inventor Nicolas Floch

Nicolas Floch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CANCER
    Publication number: 20230056604
    Abstract: The specification relates to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) for use in the treatment of cancer, wherein the EGFR TKI is administered in combination with a Smac mimetic.
    Type: Application
    Filed: January 19, 2021
    Publication date: February 23, 2023
    Inventors: Nicolas FLOCH, Paul David SMITH, Matthew Joseph MARTIN
  • EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CANCER
    Publication number: 20210161897
    Abstract: The specification relates to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) for use in the treatment of cancer, wherein the EGFR TKI is administered in combination with AZD2811.
    Type: Application
    Filed: November 11, 2020
    Publication date: June 3, 2021
    Inventors: Nicolas Floch, Paul David Smith, Matthew Joseph Martin